endocrinological test (others)

TOP
endocrinology test
endocrinological test (others)

Laboratory：Akiruno

○endocrinological test (others)

TEST NAME	SPECIMEN REQUIREMENT （ｍL）	CONTAINER	CAP COLOR	STORE TEMPERATURE (STABILITY)	TURNAROUND TIME (DAY)	METHODOLOGY	REFERENCE RANGE (UNIT)
Aldosterone〔CLEIA〕	Plasma 0.5	PN2,PN5 ↓ A00		（21 days）	2-4	CLEIA CLEIA (Chemiluminescent enzyme immunoassay) Chemiluminescent enzyme immunoassay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is subjected to a secondary reaction with the antigen, and a chemiluminescent substrate is added. method to measure luminescence intensity.	4.0-82.1(pg/mL)
Aldosterone〔CLEIA〕	Serum 0.5	S09 ↓ A00		（21 days）	2-4	CLEIA CLEIA (Chemiluminescent enzyme immunoassay) Chemiluminescent enzyme immunoassay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is subjected to a secondary reaction with the antigen, and a chemiluminescent substrate is added. method to measure luminescence intensity.	4.0-82.1(pg/mL)
Aldosterone〔CLEIA〕	Urine storage 1.5	A00		（21 days）	5-7	CLEIA CLEIA (Chemiluminescent enzyme immunoassay) Chemiluminescent enzyme immunoassay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is subjected to a secondary reaction with the antigen, and a chemiluminescent substrate is added. method to measure luminescence intensity.	1.0-19.3 (μg/day)
Active renin concentration(ARC)〔CLEIA〕	Plasma 0.5	PN2,PN5 ↓ A00		（21 days）	2-4	CLEIA CLEIA (Chemiluminescent enzyme immunoassay) Chemiluminescent enzyme immunoassay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is subjected to a secondary reaction with the antigen, and a chemiluminescent substrate is added. method to measure luminescence intensity.	2.21-39.5(pg/mL)
Plasma renin activity (PRA)〔EIA〕	Plasma 0.7	PN2,PN5 ↓ A00		（14 days）	3-5	Enzyme immunoassay(EIA) EIA (Enzyme immunoassay) Enzyme immunoassay The measurement principle is the same as RIA; an antigen-antibody reaction is performed using an enzyme-labeled antigen or antibody as a labeling substance, and a chromogenic substrate is added to detect enzyme activity. How to measure.	Lying position 0.2-2.3 Sitting position 0.2-3.9 Standing position 0.2-4.1 (ng/mL/hr)
Aldosterone 〔CLEIA〕/renin concentration ratio	Plasma 1.0	PN2,PN5 ↓ A00		（21 days）	2-4	CLEIA CLEIA (Chemiluminescent enzyme immunoassay) Chemiluminescent enzyme immunoassay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is subjected to a secondary reaction with the antigen, and a chemiluminescent substrate is added. method to measure luminescence intensity.	See below
Aldosterone 〔CLEIA〕/renin activity ratio	Plasma 1.2	PN2,PN5 ↓ A00		（14 days）	3-5	Aldosterone: CLEIA Renin activity: EIA	See below
Cyclic AMP	Plasma 0.3	PN2,PN5 ↓ A00		（1 month）	Please contact us in advance.	RIA DCC method RIA (Radio immunoassay) Radioimmunoassay A competitive antigen-antibody reaction is performed between an antigen labeled with a radioisotope (RI) against an antibody and the antigen in the sample, and the labeled antigen bound to the antibody is A method in which labeled antigen (bound) and labeled antigen that is not bound to the antibody (free) are separated, and the ratio is measured as the antigen concentration from radioactivity. Methods for separating bound and free forms (B/F separation) include the solid phase method in which antibodies are immobilized, the two-antibody method in which a second antibody is bound to the antigen-antibody complex and precipitated, and the antigen-antibody complex Examples include the ammonium sulfate salting out method in which the complex is precipitated with ammonium sulfate, and the PEG method in which the antigen-antibody complex is precipitated with a precipitation reagent.	11-21(pmol/mL)
Cyclic AMP	Urine storage 1	U00			Please contact us in advance.	RIA DCC method RIA (Radio immunoassay) Radioimmunoassay A competitive antigen-antibody reaction is performed between an antigen labeled with a radioisotope (RI) against an antibody and the antigen in the sample, and the labeled antigen bound to the antibody is A method in which labeled antigen (bound) and labeled antigen that is not bound to the antibody (free) are separated, and the ratio is measured as the antigen concentration from radioactivity. Methods for separating bound and free forms (B/F separation) include the solid phase method in which antibodies are immobilized, the two-antibody method in which a second antibody is bound to the antigen-antibody complex and precipitated, and the antigen-antibody complex Examples include the ammonium sulfate salting out method in which the complex is precipitated with ammonium sulfate, and the PEG method in which the antigen-antibody complex is precipitated with a precipitation reagent.	1.8-6.3(μmol/day)
Human atrial natriuretic peptide (HANP)	Plasma 0.5	PAP ↓ A00		（21 days）	2-4	CLEIA CLEIA (Chemiluminescent enzyme immunoassay) Chemiluminescent enzyme immunoassay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is subjected to a secondary reaction with the antigen, and a chemiluminescent substrate is added. method to measure luminescence intensity.	43.0 or less (pg/mL)
Human brain natriuretic peptide (BNP)	Plasma 0.5	PN2,PN5 ↓ A00			2-4	CLEIA CLEIA (Chemiluminescent enzyme immunoassay) Chemiluminescent enzyme immunoassay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is subjected to a secondary reaction with the antigen, and a chemiluminescent substrate is added. method to measure luminescence intensity.	18.4 or less (pg/mL)
N-terminal fragment of human brain natriuretic peptide precursor (NTproBNP)	Serum 0.4	S09 ↓ A00			2-4	ECLIA ECLIA (Electro chemiluminescence immunoassay) Electro chemiluminescence immunoassay method . A method to measure the luminescence intensity of a ruthenium pyridine complex by reaction.	125 or less (pg/mL)
Erythropoietin	Serum 0.8	S09 ↓ A00		（28 days）	2-4	CLEIA CLEIA (Chemiluminescent enzyme immunoassay) Chemiluminescent enzyme immunoassay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is subjected to a secondary reaction with the antigen, and a chemiluminescent substrate is added. method to measure luminescence intensity.	4.2-23.7(mIU/mL)
Osteocalcin	Serum 0.3	S09 ↓ A00			2-4	ECLIA ECLIA (Electro chemiluminescence immunoassay) Electro chemiluminescence immunoassay method . A method to measure the luminescence intensity of a ruthenium pyridine complex by reaction.	Premenopausal women 7.8-30.8 Postmenopausal women 14.2-54.8 Men 8.4-33.1 (ng/mL)
Undercarboxylated osteocalcin (ucOC)	Serum 0.5	S09 ↓ A00		（21 days）	2-4	ECLIA ECLIA (Electro chemiluminescence immunoassay) Electro chemiluminescence immunoassay method . A method to measure the luminescence intensity of a ruthenium pyridine complex by reaction.	Less than 4.50 (ng/mL)
Hepatocyte growth factor (HGF)	Serum 0.3	S09 ↓ A00		（1 month）	2-8	ELISA ELISA (Enzyme-Linked immunosorbent assay) Enzyme-linked immunosorbent assay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is reacted with the antigen secondarily, and a chromogenic substrate is added. A method of measuring enzyme activity.	0.39 or less (ng/mL)
FGF23〔CLEIA〕	Serum 0.4	S09 ↓ A00		（21 days）	4-10	CLEIA CLEIA (Chemiluminescent enzyme immunoassay) Chemiluminescent enzyme immunoassay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is subjected to a secondary reaction with the antigen, and a chemiluminescent substrate is added. method to measure luminescence intensity.	19.9-52.9 (pg/mL)
Adiponectin〔LA〕	Serum 0.5	S09 ↓ A00			2-4	Latex immunoturbidimetry	4.0 or more (μg/mL)
Leptin〔ELISA〕	Serum 0.3	S09 ↓ A00		（7 days）	Please contact us in advance.	ELISA ELISA (Enzyme-Linked immunosorbent assay) Enzyme-linked immunosorbent assay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is reacted with the antigen secondarily, and a chromogenic substrate is added. A method of measuring enzyme activity.	M 0.6-8.9 F 1.9-26.6 (ng/mL)
sFlt-1/PlGF ratio	Serum 0.7	S09 ↓ A00		（7 days）	2-6	ECLIA ECLIA (Electro chemiluminescence immunoassay) Electro chemiluminescence immunoassay method . A method to measure the luminescence intensity of a ruthenium pyridine complex by reaction.	38.0 or less
FGF-23（Suspended beyond orders placed 03-31-2020）	Serum 0.3	S09 ↓ A00		（14 days）	2-8	ELISA ELISA (Enzyme-Linked immunosorbent assay) A method in which after reacting an antigen with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, and the enzyme activity is measured by adding a chromogenic substrate.	16-69(pg/mL)
Osteocalcin（Suspended beyond orders placed 03-31-2016）	Serum 0.2	S09 ↓ A00				RIA solid phase method (IRMA) IRMA (Immuno radio metric assay) Immuno radiometric assay One of the RIA methods in which an antigen is reacted with a solid-phase antibody, followed by a secondary reaction of the antigen with a radioisotope (RI)-labeled antibody. This method is also called the sandwich method because a solid-phase antibody and a labeled antibody bind to each other by sandwiching the antigen.	2.5-13(ng/mL)
Aldosterone/Renin activity ratio（Suspended beyond orders placed 12-01-2022）	Plasma 1.2	PN2,PN5 ↓ A00		（14 days）	3-5	Aldosterone: CLEIA Renin activity: EIA	See below
Aldosterone/Active renin concentration ratio（Suspended beyond orders placed 12-01-2022）	Plasma 1.0	PN2,PN5 ↓ A00		（21 days）	2-4	CLEIA CLEIA (Chemiluminescent enzyme immunoassay) A method in which an antigen is reacted with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, a chemiluminescent substrate is added and the luminescence intensity is measured.	See below
Angiotensin I（Suspended beyond orders placed 03-31-2022）	Plasma 0.2	PN2,PN5 ↓ A00			6-12	RIA2 antibody method RIA (Radio immunoassay) Radioimmunoassay A method to perform the competitive antigen-antibody reaction between the antigen labeled with radioisotope (RI) against the antibody and the antigen in the specimen, and to separate the labeled antigen bound to the antibody (bound type: Bound) from the labeled antigen not bound to the antibody (free type: Free) and to measure the ratio of them as the antigen concentration from the radioactivity. As separation methods for bound and free types (B/F separation), there are the solid-phase method in which the antibody is solid-phased, the two-antibody method in which a second antibody is bound to the antigen-antibody complex and precipitated, the ammonium sulfate precipitation method in which the antigen-antibody complex is precipitated with ammonium sulfate (ammonium sulfate), and the PEG method in which the antigen-antibody complex is precipitated with a precipitation reagent.	110 or less (pg/mL)
Angiotensin II（Suspended beyond orders placed 03-31-2022）	Plasma 0.3	PN2,PN5 ↓ A00			6-12	RIA2 antibody method RIA (Radio immunoassay) Radioimmunoassay A method to perform the competitive antigen-antibody reaction between the antigen labeled with radioisotope (RI) against the antibody and the antigen in the specimen, and to separate the labeled antigen bound to the antibody (bound type: Bound) from the labeled antigen not bound to the antibody (free type: Free) and to measure the ratio of them as the antigen concentration from the radioactivity. As separation methods for bound and free types (B/F separation), there are the solid-phase method in which the antibody is solid-phased, the two-antibody method in which a second antibody is bound to the antigen-antibody complex and precipitated, the ammonium sulfate precipitation method in which the antigen-antibody complex is precipitated with ammonium sulfate (ammonium sulfate), and the PEG method in which the antigen-antibody complex is precipitated with a precipitation reagent.	22 or less (pg/mL)
Renin quantification (active form)（Suspended beyond orders placed 03-31-2021）	Plasma 0.5	PN2,PN5 ↓ A00		（20 days）	2-5	RIA solid phase method (IRMA) IRMA (Immuno radio metric assay) Immuno radiometric assay One of the RIA methods in which an antigen is reacted with a solid-phase antibody, followed by a secondary reaction of the antigen with a radioisotope (RI)-labeled antibody. This method is also called the sandwich method because a solid-phase antibody and a labeled antibody bind to each other by sandwiching the antigen.	Any time 3.2-36 lying position 2.5-21 standing position 3.6-64 (pg/mL)
Plasma renin activity(PRA)（Suspended beyond orders placed 03-31-2021）	Plasma 0.3	PN2,PN5 ↓ A00		（1 month）	3-5	RIA2 antibody method RIA (Radio immunoassay) Radioimmunoassay A method to perform the competitive antigen-antibody reaction between the antigen labeled with radioisotope (RI) against the antibody and the antigen in the specimen, and to separate the labeled antigen bound to the antibody (bound type: Bound) from the labeled antigen not bound to the antibody (free type: Free) and to measure the ratio of them as the antigen concentration from the radioactivity. As separation methods for bound and free types (B/F separation), there are the solid-phase method in which the antibody is solid-phased, the two-antibody method in which a second antibody is bound to the antigen-antibody complex and precipitated, the ammonium sulfate precipitation method in which the antigen-antibody complex is precipitated with ammonium sulfate (ammonium sulfate), and the PEG method in which the antigen-antibody complex is precipitated with a precipitation reagent.	Lying position 0.3-2.9 Standing position 0.3-5.4 (ng/mL/hr)

TEST NAME	SPECIMEN REQUIREMENT （ｍL）	CONTAINER	CAP COLOR	STORE TEMPERATURE (STABILITY)	TURNAROUND TIME (DAY)	METHODOLOGY	REFERENCE RANGE (UNIT)
Aldosterone〔CLEIA〕	Plasma 0.5	PN2,PN5 ↓ A00		（21 days）	2-4	CLEIA CLEIA (Chemiluminescent enzyme immunoassay) Chemiluminescent enzyme immunoassay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is subjected to a secondary reaction with the antigen, and a chemiluminescent substrate is added. method to measure luminescence intensity.	4.0-82.1(pg/mL)
Aldosterone〔CLEIA〕	Serum 0.5	S09 ↓ A00		（21 days）	2-4	CLEIA CLEIA (Chemiluminescent enzyme immunoassay) Chemiluminescent enzyme immunoassay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is subjected to a secondary reaction with the antigen, and a chemiluminescent substrate is added. method to measure luminescence intensity.	4.0-82.1(pg/mL)
Aldosterone〔CLEIA〕	Urine storage 1.5	A00		（21 days）	5-7	CLEIA CLEIA (Chemiluminescent enzyme immunoassay) Chemiluminescent enzyme immunoassay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is subjected to a secondary reaction with the antigen, and a chemiluminescent substrate is added. method to measure luminescence intensity.	1.0-19.3 (μg/day)
Active renin concentration(ARC)〔CLEIA〕	Plasma 0.5	PN2,PN5 ↓ A00		（21 days）	2-4	CLEIA CLEIA (Chemiluminescent enzyme immunoassay) Chemiluminescent enzyme immunoassay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is subjected to a secondary reaction with the antigen, and a chemiluminescent substrate is added. method to measure luminescence intensity.	2.21-39.5(pg/mL)
Plasma renin activity (PRA)〔EIA〕	Plasma 0.7	PN2,PN5 ↓ A00		（14 days）	3-5	Enzyme immunoassay(EIA) EIA (Enzyme immunoassay) Enzyme immunoassay The measurement principle is the same as RIA; an antigen-antibody reaction is performed using an enzyme-labeled antigen or antibody as a labeling substance, and a chromogenic substrate is added to detect enzyme activity. How to measure.	Lying position 0.2-2.3 Sitting position 0.2-3.9 Standing position 0.2-4.1 (ng/mL/hr)
Aldosterone 〔CLEIA〕/renin concentration ratio	Plasma 1.0	PN2,PN5 ↓ A00		（21 days）	2-4	CLEIA CLEIA (Chemiluminescent enzyme immunoassay) Chemiluminescent enzyme immunoassay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is subjected to a secondary reaction with the antigen, and a chemiluminescent substrate is added. method to measure luminescence intensity.	See below
Aldosterone 〔CLEIA〕/renin activity ratio	Plasma 1.2	PN2,PN5 ↓ A00		（14 days）	3-5	Aldosterone: CLEIA Renin activity: EIA	See below
Cyclic AMP	Plasma 0.3	PN2,PN5 ↓ A00		（1 month）	Please contact us in advance.	RIA DCC method RIA (Radio immunoassay) Radioimmunoassay A competitive antigen-antibody reaction is performed between an antigen labeled with a radioisotope (RI) against an antibody and the antigen in the sample, and the labeled antigen bound to the antibody is A method in which labeled antigen (bound) and labeled antigen that is not bound to the antibody (free) are separated, and the ratio is measured as the antigen concentration from radioactivity. Methods for separating bound and free forms (B/F separation) include the solid phase method in which antibodies are immobilized, the two-antibody method in which a second antibody is bound to the antigen-antibody complex and precipitated, and the antigen-antibody complex Examples include the ammonium sulfate salting out method in which the complex is precipitated with ammonium sulfate, and the PEG method in which the antigen-antibody complex is precipitated with a precipitation reagent.	11-21(pmol/mL)
Cyclic AMP	Urine storage 1	U00			Please contact us in advance.	RIA DCC method RIA (Radio immunoassay) Radioimmunoassay A competitive antigen-antibody reaction is performed between an antigen labeled with a radioisotope (RI) against an antibody and the antigen in the sample, and the labeled antigen bound to the antibody is A method in which labeled antigen (bound) and labeled antigen that is not bound to the antibody (free) are separated, and the ratio is measured as the antigen concentration from radioactivity. Methods for separating bound and free forms (B/F separation) include the solid phase method in which antibodies are immobilized, the two-antibody method in which a second antibody is bound to the antigen-antibody complex and precipitated, and the antigen-antibody complex Examples include the ammonium sulfate salting out method in which the complex is precipitated with ammonium sulfate, and the PEG method in which the antigen-antibody complex is precipitated with a precipitation reagent.	1.8-6.3(μmol/day)
Human atrial natriuretic peptide (HANP)	Plasma 0.5	PAP ↓ A00		（21 days）	2-4	CLEIA CLEIA (Chemiluminescent enzyme immunoassay) Chemiluminescent enzyme immunoassay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is subjected to a secondary reaction with the antigen, and a chemiluminescent substrate is added. method to measure luminescence intensity.	43.0 or less (pg/mL)
Human brain natriuretic peptide (BNP)	Plasma 0.5	PN2,PN5 ↓ A00			2-4	CLEIA CLEIA (Chemiluminescent enzyme immunoassay) Chemiluminescent enzyme immunoassay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is subjected to a secondary reaction with the antigen, and a chemiluminescent substrate is added. method to measure luminescence intensity.	18.4 or less (pg/mL)
N-terminal fragment of human brain natriuretic peptide precursor (NTproBNP)	Serum 0.4	S09 ↓ A00			2-4	ECLIA ECLIA (Electro chemiluminescence immunoassay) Electro chemiluminescence immunoassay method . A method to measure the luminescence intensity of a ruthenium pyridine complex by reaction.	125 or less (pg/mL)
Erythropoietin	Serum 0.8	S09 ↓ A00		（28 days）	2-4	CLEIA CLEIA (Chemiluminescent enzyme immunoassay) Chemiluminescent enzyme immunoassay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is subjected to a secondary reaction with the antigen, and a chemiluminescent substrate is added. method to measure luminescence intensity.	4.2-23.7(mIU/mL)
Osteocalcin	Serum 0.3	S09 ↓ A00			2-4	ECLIA ECLIA (Electro chemiluminescence immunoassay) Electro chemiluminescence immunoassay method . A method to measure the luminescence intensity of a ruthenium pyridine complex by reaction.	Premenopausal women 7.8-30.8 Postmenopausal women 14.2-54.8 Men 8.4-33.1 (ng/mL)
Undercarboxylated osteocalcin (ucOC)	Serum 0.5	S09 ↓ A00		（21 days）	2-4	ECLIA ECLIA (Electro chemiluminescence immunoassay) Electro chemiluminescence immunoassay method . A method to measure the luminescence intensity of a ruthenium pyridine complex by reaction.	Less than 4.50 (ng/mL)
Hepatocyte growth factor (HGF)	Serum 0.3	S09 ↓ A00		（1 month）	2-8	ELISA ELISA (Enzyme-Linked immunosorbent assay) Enzyme-linked immunosorbent assay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is reacted with the antigen secondarily, and a chromogenic substrate is added. A method of measuring enzyme activity.	0.39 or less (ng/mL)
FGF23〔CLEIA〕	Serum 0.4	S09 ↓ A00		（21 days）	4-10	CLEIA CLEIA (Chemiluminescent enzyme immunoassay) Chemiluminescent enzyme immunoassay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is subjected to a secondary reaction with the antigen, and a chemiluminescent substrate is added. method to measure luminescence intensity.	19.9-52.9 (pg/mL)
Adiponectin〔LA〕	Serum 0.5	S09 ↓ A00			2-4	Latex immunoturbidimetry	4.0 or more (μg/mL)
Leptin〔ELISA〕	Serum 0.3	S09 ↓ A00		（7 days）	Please contact us in advance.	ELISA ELISA (Enzyme-Linked immunosorbent assay) Enzyme-linked immunosorbent assay After reacting the antigen with the immobilized antibody, the enzyme-labeled antibody is reacted with the antigen secondarily, and a chromogenic substrate is added. A method of measuring enzyme activity.	M 0.6-8.9 F 1.9-26.6 (ng/mL)
sFlt-1/PlGF ratio	Serum 0.7	S09 ↓ A00		（7 days）	2-6	ECLIA ECLIA (Electro chemiluminescence immunoassay) Electro chemiluminescence immunoassay method . A method to measure the luminescence intensity of a ruthenium pyridine complex by reaction.	38.0 or less
FGF-23（Suspended beyond orders placed 03-31-2020）	Serum 0.3	S09 ↓ A00		（14 days）	2-8	ELISA ELISA (Enzyme-Linked immunosorbent assay) A method in which after reacting an antigen with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, and the enzyme activity is measured by adding a chromogenic substrate.	16-69(pg/mL)
Osteocalcin（Suspended beyond orders placed 03-31-2016）	Serum 0.2	S09 ↓ A00				RIA solid phase method (IRMA) IRMA (Immuno radio metric assay) Immuno radiometric assay One of the RIA methods in which an antigen is reacted with a solid-phase antibody, followed by a secondary reaction of the antigen with a radioisotope (RI)-labeled antibody. This method is also called the sandwich method because a solid-phase antibody and a labeled antibody bind to each other by sandwiching the antigen.	2.5-13(ng/mL)
Aldosterone/Renin activity ratio（Suspended beyond orders placed 12-01-2022）	Plasma 1.2	PN2,PN5 ↓ A00		（14 days）	3-5	Aldosterone: CLEIA Renin activity: EIA	See below
Aldosterone/Active renin concentration ratio（Suspended beyond orders placed 12-01-2022）	Plasma 1.0	PN2,PN5 ↓ A00		（21 days）	2-4	CLEIA CLEIA (Chemiluminescent enzyme immunoassay) A method in which an antigen is reacted with a solid-phase antibody, an enzyme-labeled antibody is reacted with the antigen in a secondary reaction, a chemiluminescent substrate is added and the luminescence intensity is measured.	See below
Angiotensin I（Suspended beyond orders placed 03-31-2022）	Plasma 0.2	PN2,PN5 ↓ A00			6-12	RIA2 antibody method RIA (Radio immunoassay) Radioimmunoassay A method to perform the competitive antigen-antibody reaction between the antigen labeled with radioisotope (RI) against the antibody and the antigen in the specimen, and to separate the labeled antigen bound to the antibody (bound type: Bound) from the labeled antigen not bound to the antibody (free type: Free) and to measure the ratio of them as the antigen concentration from the radioactivity. As separation methods for bound and free types (B/F separation), there are the solid-phase method in which the antibody is solid-phased, the two-antibody method in which a second antibody is bound to the antigen-antibody complex and precipitated, the ammonium sulfate precipitation method in which the antigen-antibody complex is precipitated with ammonium sulfate (ammonium sulfate), and the PEG method in which the antigen-antibody complex is precipitated with a precipitation reagent.	110 or less (pg/mL)
Angiotensin II（Suspended beyond orders placed 03-31-2022）	Plasma 0.3	PN2,PN5 ↓ A00			6-12	RIA2 antibody method RIA (Radio immunoassay) Radioimmunoassay A method to perform the competitive antigen-antibody reaction between the antigen labeled with radioisotope (RI) against the antibody and the antigen in the specimen, and to separate the labeled antigen bound to the antibody (bound type: Bound) from the labeled antigen not bound to the antibody (free type: Free) and to measure the ratio of them as the antigen concentration from the radioactivity. As separation methods for bound and free types (B/F separation), there are the solid-phase method in which the antibody is solid-phased, the two-antibody method in which a second antibody is bound to the antigen-antibody complex and precipitated, the ammonium sulfate precipitation method in which the antigen-antibody complex is precipitated with ammonium sulfate (ammonium sulfate), and the PEG method in which the antigen-antibody complex is precipitated with a precipitation reagent.	22 or less (pg/mL)
Renin quantification (active form)（Suspended beyond orders placed 03-31-2021）	Plasma 0.5	PN2,PN5 ↓ A00		（20 days）	2-5	RIA solid phase method (IRMA) IRMA (Immuno radio metric assay) Immuno radiometric assay One of the RIA methods in which an antigen is reacted with a solid-phase antibody, followed by a secondary reaction of the antigen with a radioisotope (RI)-labeled antibody. This method is also called the sandwich method because a solid-phase antibody and a labeled antibody bind to each other by sandwiching the antigen.	Any time 3.2-36 lying position 2.5-21 standing position 3.6-64 (pg/mL)
Plasma renin activity(PRA)（Suspended beyond orders placed 03-31-2021）	Plasma 0.3	PN2,PN5 ↓ A00		（1 month）	3-5	RIA2 antibody method RIA (Radio immunoassay) Radioimmunoassay A method to perform the competitive antigen-antibody reaction between the antigen labeled with radioisotope (RI) against the antibody and the antigen in the specimen, and to separate the labeled antigen bound to the antibody (bound type: Bound) from the labeled antigen not bound to the antibody (free type: Free) and to measure the ratio of them as the antigen concentration from the radioactivity. As separation methods for bound and free types (B/F separation), there are the solid-phase method in which the antibody is solid-phased, the two-antibody method in which a second antibody is bound to the antigen-antibody complex and precipitated, the ammonium sulfate precipitation method in which the antigen-antibody complex is precipitated with ammonium sulfate (ammonium sulfate), and the PEG method in which the antigen-antibody complex is precipitated with a precipitation reagent.	Lying position 0.3-2.9 Standing position 0.3-5.4 (ng/mL/hr)

TEST DIRECTORY

○endocrinological test (others)

Notifications of URL changes/lab information added

ラボを選択してください

Choose a laboratory

Notifications of URL changes/lab information added

Laboratory List

Advanced search